Valeur Eric, Narjes Frank, Ottmann Christian, Plowright Alleyn T
Medicinal Chemistry , Research and Early Development, Cardiovascular, Renal & Metabolism , BioPharmaceuticals R&D , AstraZeneca, Gothenburg , 43183 Mölndal , Sweden . Email:
Medicinal Chemistry , Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA) , BioPharmaceuticals R&D , AstraZeneca, Gothenburg , 43183 Mölndal , Sweden.
Medchemcomm. 2019 Jun 25;10(9):1550-1568. doi: 10.1039/c9md00263d. eCollection 2019 Sep 1.
An increasing focus on complex biology to cure diseases rather than merely treat symptoms has transformed how drug discovery can be approached. Instead of activating or blocking protein function, a growing repertoire of drug modalities can be leveraged or engineered to hijack cellular processes, such as translational regulation or degradation mechanisms. Drug hunters can therefore access a wider arsenal of modes-of-action to modulate biological processes and this review summarises these emerging strategies by highlighting the most representative examples of these approaches.
对复杂生物学的日益关注,旨在治愈疾病而非仅仅治疗症状,这已经改变了药物研发的方式。如今,越来越多的药物作用方式可供利用或设计,以操控细胞过程,如翻译调控或降解机制,而不再局限于激活或阻断蛋白质功能。因此,药物研发人员能够采用更广泛的作用方式来调节生物学过程,本综述通过突出这些方法中最具代表性的例子,总结了这些新兴策略。